Gentherm price target lowered to $39 from $44 at Roth Capital

Roth Capital lowered the firm’s price target on Gentherm (THRM) to $39 from $44 and keeps a Buy rating on the shares. The firm anticipates the company’s sales and adjusted EBITDA to come in below the midpoint of 2026 guidance, the analyst tells investors in a research note. Roth remains positive on Gentherm’s adjacent market growth traction and an improving margin set up into 2027 but also notes the recent macro disruption that could keep the stock range-bound while investors await clarity, the firm added.